Misoprostol for the Treatment of Incomplete Abortion
NCT00670761 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 720
Last updated 2016-07-27
Summary
This randomized study will examine the efficacy, safety and acceptability of misoprostol for treatment of incomplete abortion.
Women diagnosed with incomplete abortion will be randomized to receive one of the following regimens:
In Tanzania and Mozambique:
1. 600 mcg of oral misoprostol in one dose, or
2. Standard surgical treatment (MVA)
In Moldova and Madagascar:
1. 600 mcg of oral misoprostol in one dose, or
2. 400 mcg of sublingual misoprostol in one dose.
In Burkina Faso and Vietnam:
1\. 400 mcg of sublingual misoprostol in one dose.
We hypothesize that treatment of incomplete abortion with either 400 mcg sublingual misoprostol, 600 mcg oral misoprostol or MVA are equally effective in evacuating the uterus.
Conditions
- Abortion, Incomplete
Interventions
- DRUG
-
comparison of orally administered 600mcg of misoprostol to either sublingually administered 400mcg or Manual Vacuum Aspiration (MVA)
- PROCEDURE
-
MVA
comparison of orally administered 600mcg of misoprostol to either sublingually administered 400mcg or Manual Vacuum Aspiration (MVA)
Sponsors & Collaborators
-
Befelatanana Maternity Centre
collaborator UNKNOWN -
Municipal Clinical Hospital No. 1
collaborator UNKNOWN -
Kagera Regional Hospital
collaborator OTHER -
Jose Macamo Hospital
collaborator UNKNOWN -
Tudu hospital
collaborator UNKNOWN -
National OBGYN hospital
collaborator UNKNOWN -
Cuchi General District hospital
collaborator UNKNOWN -
Hôpital de District Sanitaire Dandé
collaborator UNKNOWN -
Hôpital de District Sanitaire de Ziniaré
collaborator UNKNOWN -
Gynuity Health Projects
lead OTHER
Principal Investigators
-
Beverly Winikoff, MD, MPH · Gynuity Health Projects
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-07-31
- Primary Completion
- 2010-04-30
- Completion
- 2010-12-31
Countries
- Burkina Faso
- Madagascar
- Moldova
- Mozambique
- Tanzania
Study Locations
More Related Trials
-
Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso
NCT03269279 ·Status: UNKNOWN ·Phase: PHASE3
-
Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days Gestation
NCT01966874 ·Status: COMPLETED
-
Misoprostol Treatment of Mid Trimester Incomplete Abortion by Midwives and Doctors in Uganda.
NCT03622073 ·Status: COMPLETED ·Phase: NA
-
Mifepristone and Misoprostol for the Termination of Pregnancy up to 70 Days' Gestation in Kazakhstan
NCT02018796 ·Status: COMPLETED
-
MisOpRostol Effect on Second Trimester Abortion Blood Loss
NCT06078501 ·Status: TERMINATED ·Phase: PHASE3
-
Mifepristone-misoprostol vs. Misoprostol Alone for Second Trimester Fetal Death
NCT02633761 ·Status: TERMINATED ·Phase: PHASE3
-
Misoprostol for Treatment of Fetal Death at 14-28 Weeks of Pregnancy
NCT00671060 ·Status: COMPLETED ·Phase: PHASE3
-
The Extended Gestational Age Medical Abortion Study
NCT00997347 ·Status: COMPLETED ·Phase: PHASE4
-
Same-Day Mifepristone-Misoprostol Compared to Misoprostol Only for Surgical Abortion Cervical Preparation
NCT02412618 ·Status: COMPLETED ·Phase: PHASE4
-
400mcg Sublingual Misoprostol as First Line Treatment
NCT01939457 ·Status: COMPLETED ·Phase: NA
-
Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion
NCT05001061 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Mifepristone Plus Misoprostol Versus Misoprostol Alone for 2nd Trimester Abortion (14 - 21 Weeks Last Menstrual Period (LMP))
NCT00969982 ·Status: COMPLETED ·Phase: NA
-
Vaginal Misoprostol In Management Of First Trimester Missed Abortion.
NCT03148314 ·Status: COMPLETED ·Phase: PHASE2
-
Misoprostol in Missed Abortion
NCT06818903 ·Status: NOT_YET_RECRUITING
-
Acceptability of an Out-patient Regimen of Medical Abortion With Mifepristone and 800 Mcg Misoprostol Administered at 78-84 Days Gestation
NCT01856985 ·Status: COMPLETED ·Phase: PHASE4
-
Medical Termination of II Trimester Pregnancy
NCT03600857 ·Status: COMPLETED ·Phase: PHASE4
-
A Comparison of Sublingual and Buccal Misoprostol Regimens After Mifepristone for Mid-trimester Abortion
NCT02708446 ·Status: UNKNOWN ·Phase: PHASE4
-
Mifepristone and Misoprostol Versus Misoprostol Alone for Mid-trimester Termination of Pregnancy (14-21 Weeks LMP)
NCT00957346 ·Status: TERMINATED ·Phase: PHASE3
-
Comparing Two Regimens for Medical Abortion: Mifepristone+Misoprostol Versus Misoprostol Alone
NCT00680394 ·Status: COMPLETED ·Phase: NA
-
Misoprostol for Non-Viable Pregnancies
NCT00426491 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Two Regimens of Misoprostol Alone for Early Pregnancy Termination and Use of SQPT for At-Home Follow-Up
NCT02299401 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Misoprostol for Management of Women With an Incomplete Miscarriage
NCT05088720 ·Status: UNKNOWN ·Phase: NA
-
Misoprostol for Second Trimester Pregnancy Termination
NCT02669420 ·Status: COMPLETED ·Phase: PHASE2
-
Mifepristone and Misoprostol Versus Misoprostol Alone in the Medical Management of Missed Miscarriage
NCT03065660 ·Status: COMPLETED ·Phase: PHASE3
-
Misoprostol for Preventing Postpartum Hemorrhage
NCT00124540 ·Status: COMPLETED ·Phase: NA